Consortium Awarded $30 Million for Manufacturing Pilot Program
Client Alert | 1 min read | 08.23.12
On August 16, the Obama administration announced both a $30 million award that may serve as a model for future partnerships geared towards manufacturing innovation to the National Additive Manufacturing Innovation Institute (NAMII) and a "pilot" program for the Administration's National Network of Manufacturing Innovation plan to invest $1 billion "to catalyze a national network of up to 15 manufacturing innovation institutes around the country." NAMII, which was selected in response to a Broad Agency Announcement solicitation, is a consortium including dozens of major government contractors and manufacturing firms, universities, and non-profit organizations which will "co-invest" $40 million to develop additive manufacturing technology (a process by which products and components are manufactured more efficiently using digital models).
Contacts
Insights
Client Alert | 9 min read | 10.21.26
The life sciences sector is uniquely vulnerable to the inherent risks of AI-generated evidence in drug development and discovery. This client alert focuses on five core challenges: hallucinations, skewed predictions from unrepresentative training data, the opacity of AI reasoning, input sensitivity that undermines reproducibility, and adversarial manipulation of training data. To address these risks, companies should use experimental validation and human oversight as the common legal and regulatory safety net. This entails among other measures auditing AI outputs, characterizing training data, and structural oversight. Companies also should prepare for evolving frameworks and guidance from the U.S. Food and Drug Administration (FDA) and the European Union (EU) that address use of AI in drug discovery and development .
Client Alert | 2 min read | 10.21.26
Client Alert | 3 min read | 10.21.26
Private Investigations Act Series: Temporal, material and territorial scope
Client Alert | 7 min read | 10.21.26
